---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-021218"
form_type: "8-K"
ticker: "NKTX"
cik: "0001787400"
company_name: "Nkarta, Inc."
filed_at: "2023-05-11T23:59:59+00:00"
generated_at: "2026-06-15T04:31:16.766982+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Nkarta Q1 net loss $30.8M, cash $332.1M, CFO resigning

## Summary
- Net loss of $30.8M ($0.63 per share) for Q1 2023; R&D expenses $26.1M, G&A $8.2M.
- Cash and equivalents $332.1M as of March 31, 2023; runway expected into 2025.
- CFO Nadir Mahmood resigning effective June 30, 2023; successor search underway.
- NKX101 clinical update planned for Q2 2023; NKX019 update in H2 2023.
- Preclinical data on NK cell engineering presented at AACR 2023.

## SEC filing metadata
- accession: 0000950170-23-021218
- form_type: 8-K
- ticker: NKTX
- cik: 0001787400
- company_name: Nkarta, Inc.
- filed_at: 2023-05-11T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1787400/000095017023021218/0000950170-23-021218-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1787400/000095017023021218/nktx-20230511.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-021218
- JSON: https://secwatch.observer/filing/0000950170-23-021218.json
- Plain text: https://secwatch.observer/filing/0000950170-23-021218.txt

## Key facts
- Earnings Releases
  Nkarta, Inc. reported for the first quarter ended March 31, 2023 results: net income $30.8 million, EPS $0.63 per basic and diluted share. Guidance initiated.
  - Period: for the first quarter ended March 31, 2023
  - Net income: $30.8 million
  - EPS: $0.63 per basic and diluted share
  - Guidance: initiated
  - Result: reported results
  source text: Net loss was $30.8 million, or $0.63 per basic and diluted share, for the first quarter of 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1787400/000095017023021218/0000950170-23-021218-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.